Birx Deborah
Transaction: 07/10/2026
SELL
Change
-14,041
Price
$4.26
Filing
07/14/2026
Type
SELL
Armata Pharmaceuticals, Inc.
ARMP • Biotechnology
$5.84
▲ +0.32 (+5.80%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$362.32M
Growth
-9.9%
Cash Flow
0/5
Trend
Negative
Evidence
Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:22 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$5.84
Change5.80%
Shares Out62.04M
Market Cap$362.32M
Enterprise Value$446.40M
52W Range2.40 - 16.34
Beta1.31
P/E-1.89
P/S459.22
P/B-1.57
P/FCF-14.05
EV/Sales565.78
Price$5.84
Change5.80%
Shares Out62.04M
Market Cap$362.32M
Enterprise Value$446.40M
52W Range2.40 - 16.34
Beta1.31
P/E-1.89
P/S459.22
P/B-1.57
P/FCF-14.05
EV/Sales565.78
EV/EBITDA-2.99
EV/FCF-17.31
Earnings Yield-53.04%
FCF Yield-7.12%
Dividend Yield0.00%
Gross Margin68.78%
Oper. Margin-6.37%
Profit Margin-35.44%
Debt/Eq-1.32
Current Ratio1.19
Quick Ratio1.19
Revenue 5Y-9.92%
Target$15.00
Target Upside156.85%
Target Median$15.00
Target Range15.00 - 15.00
Volume165.34K
Avg Volume120.76K
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
26
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
53/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
20/100
Why this score▼
Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 4 analyst votes · 2026-09-05
100/100
Bullish
Bullish
4
Hold
0
Bearish
0
Price Target
2026-08-14
Low
$15.00
Mean
$15.00
Median
$15.00
High
$15.00
Insider Transactions
Recent executive and insider activity
Gilmer Daniel B.
Transaction: 04/24/2026
OTHER
Change
0
Price
Not reported
Filing
04/28/2026
Type
OTHER
Gilmer Daniel B.
Transaction: 04/24/2026
BUY
Change
+51,280
Price
$12.92
Filing
04/28/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Birx Deborah | SELL | -14,041 | $4.26 | 07/10/2026 | 07/14/2026 |
| Gilmer Daniel B. | OTHER | 0 | Not reported | 04/24/2026 | 04/28/2026 |
| Gilmer Daniel B. | BUY | +51,280 | $12.92 | 04/24/2026 | 04/28/2026 |
| Birx Deborah | SELL | -4,919 | $10.54 | 03/14/2026 | 03/17/2026 |
| Kyme Pierre | SELL | -1,030 | $10.54 | 03/14/2026 | 03/17/2026 |
| Haimovitz Jules | BUY | +25,640 | $11.61 | 03/09/2026 | 03/11/2026 |
| Schlesinger Sarah J. | BUY | +25,640 | $11.61 | 03/09/2026 | 03/11/2026 |
| Birx Deborah | BUY | +421,226 | $11.61 | 03/09/2026 | 03/11/2026 |
| Odysseas Kostas D | BUY | +25,640 | $11.61 | 03/09/2026 | 03/11/2026 |
| Peterson Todd C. | BUY | +25,640 | $11.61 | 03/09/2026 | 03/11/2026 |
| PATTI JOSEPH M | BUY | +25,640 | $11.61 | 03/09/2026 | 03/11/2026 |
| House David Duane | BUY | +109,885 | $11.61 | 03/09/2026 | 03/11/2026 |
| Kyme Pierre | BUY | +183,142 | $11.61 | 03/09/2026 | 03/11/2026 |
| Kramer Robin | BUY | +25,640 | $11.61 | 03/09/2026 | 03/11/2026 |
| Birx Deborah | SELL | -13,637 | $2.27 | 07/10/2025 | 07/14/2025 |
| Kyme Pierre | SELL | -1,027 | $1.95 | 03/14/2025 | 04/25/2025 |
| Birx Deborah | SELL | -6,061 | $1.95 | 03/14/2025 | 04/25/2025 |
| Birx Deborah | SELL | -22,925 | $2.68 | 07/10/2024 | 04/25/2025 |
| Kyme Pierre | OTHER | +50,000 | $5.11 | 06/19/2024 | 04/25/2025 |
| Kyme Pierre | OTHER | 0 | Not reported | 06/19/2024 | 04/25/2025 |